Givaudan

Last updated January 31, 2026

Innovation Areas

723

Inventors

Collaborations

Curcuminoid bioavailability formulation matrix: GivaudanRecent Research Landscape

Poor curcuminoid bioavailability and physical instability in aqueous solutions lead to therapeutic failure. This system utilizes specific surfactant-polymer interactions to stabilize the hydrophobic payload for consistent delivery.

What technical problems is Givaudan addressing in Curcuminoid bioavailability formulation matrix?

Oxidative mitochondrial damage

(6)evidences

Curcuminoids suffer from poor aqueous solubility and rapid metabolic clearance. Overcoming these barriers is essential for achieving therapeutic concentrations in target tissues.

Poor systemic curcuminoid bioavailability

(2)evidences

Curcuminoids suffer from low solubility and rapid metabolism which prevents therapeutic efficacy. Overcoming this limitation ensures active compounds reach target tissues to alleviate muscle soreness.

Lower urinary tract dysfunction

(2)evidences

Imbalance of the feminine genital microbiota leads to infections and inflammatory conditions. Restoring microbial equilibrium prevents pathological colonization and maintains mucosal health.